Latest News & Features
Americas
The ‘Wands factors’ are extending patent litigation—allowing functionally defined claims to survive longer than expected, hears Marisa Woutersen in Boston. 6 May 2025
Americas
Decision follows director review ordered by Kathi Vidal two years ago | Two pieces of prior art successfully cited in arguments key to invalidation. 6 May 2025
Americas
The pharma giant and biopharma company Incyte announce settlement of dispute over alleged unpaid royalties | News comes on eve of trial in Manhattan. 6 May 2025
Americas
The team brings experience in Section 337 investigations, post-grant proceedings, and complex patent litigation in biopharmaceutical and medical device sectors. 6 May 2025
Europe
Appeals court overturns lower court ruling in decision establishing key standards for patent interpretation | Global dispute between the two insulin pump makers intensifies amid separate US trade secret litigation. 2 May 2025
Americas
Latest report highlights increasing concerns over counterfeit pharmaceuticals, IP barriers, and market access challenges | Key countries to watch include India, China, the UAE, and Singapore | Report also outlines challenges in Mexico, Russia, Brazil, and Indonesia. 1 May 2025
Americas
Duo behind Comirnaty fails to convince Delaware judge to dismiss Alnylam patent claims on grounds of invalidity. 1 May 2025
Careers
The firm has rehired Kate Hillier as a partner in its Bay Area office, where she will advise public and private life sciences companies on strategic partnering, licensing and complex IP transactions. 1 May 2025
Europe
EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical contribution | Court had earlier overturned a first-instance decision allowing an injunction against Glenmark’s diabetes generic | AstraZeneca intends to appeal. 29 April 2025
Africa
Genomic innovations involve vast amounts of research, making patents, copyrights, and trade secrets vital, explains Olusola Tunmise-Ajani of Inventa International. 29 April 2025